4Thejls H, Gnarpe. J, Gnarpe H, et al. Expandod gold standard in the diagosis of Chlamydia traihomatis in a low prevalence population: diagnostic efficacy of tissue culture, direct immunofluorescence, enzyme immunoassay, PCR and serology. Genitourin Med, 1994, 70:300-303.
5Yuan Y, Zhang YX, Watkins NG, et al.Nucleotide and deduced amino acid sequences for the four variable domains of the major outer membrane protein genes of the 15 Chlamydia trachomatis serovars.Infect Immun, 1989, 57: 1040-1046.
6Sreevatsan S, Bookout JB, Ringpis FM, et al.Algorithmic approach to high-throughput molecular screening for alpha interferon-resistant genotypes in hepatitis C patients.J Clin Microbiol, 1998, 36: 1895-1901.
7Marshall DJ, Heisler LM, Lyamichev V, et al.Determination of hepatitis C virus genotypes in the United States by cleavase fragment length polymorphism analysis.J Clin Microbiol, 1997, 35: 3156-3162.
8Tondella MLC, Reeves MW, Popovic T, et al.Cleavase Fragment length polymorphism analysis of neisseria meningitidis basic metabolic genes.J Clin Microbiol, 1999, 37: 2402-2407.
9Rombout YB, Bosch S, Mandjes B, et al.Trichinella as shown by cleavase fragment length polymorphism analysis.J Helminthol, 2001, 75: 67-72.
10Sreevatsan S, Bookout JB, Ringpis FM, et al. Algorithmic approach to high-throughput molecular screening for alpha interferon-resistant genotypes in hepatitis C patients. J Clin Microbiol, 1998,36: 1895-1901.
